Health Score

0 Excellent

Metadata coverage

Abstract

ORCID

References

License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder

Award / grant

Affiliation & institutional identifiers

Affiliation

ROR ID

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

Attach ORCID iDs across 134 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact134 DOIs

Deposit reference lists for 21 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact21 DOIs

DOIs for this ISSN

Showing the top 5 of 707 DOIs, ordered by correction priority.

#	Title	Missing	Priority	Citations
1	Screening Pathways through China, the Asia Pacific Region, t… (10.3390/ijns5030026)	References ORCID	65.05	19
2	Newborn Screening for X-Linked Adrenoleukodystrophy (10.3390/ijns2040015)	ORCID	49.67	96
3	Influence of Hematocrit and Total-Spot Volume on Performance… (10.3390/ijns1020069)	ORCID	49.56	95
4	Newborn and Infant Hearing Screening Facing Globally Growing… (10.3390/ijns5010007)	ORCID	47.02	75
5	Psychosocial Issues Related to Newborn Screening: A Systemat… (10.3390/ijns8040053)	ORCID	45.81	67
6	Newborn Screening for Congenital Adrenal Hyperplasia: Review… (10.3390/ijns6030067)	ORCID	44.81	61
7	Development of Strategies to Decrease False Positive Results… (10.3390/ijns6040084)	ORCID	42.90	51
8	Newborn Screening for Lysosomal Storage Diseases: Methodolog… (10.3390/ijns4030023)	ORCID	42.69	50
9	Psychological Impact on Parents of an Inconclusive Diagnosis… (10.3390/ijns5020023)	ORCID	42.69	50
10	Universal Implementation of Newborn Screening in India (10.3390/ijns6020024)	ORCID	41.33	44
11	Landscape of Spinal Muscular Atrophy Newborn Screening in th… (10.3390/ijns7030033)	ORCID	40.84	42
12	Newborn Screening for Pompe Disease in Illinois: Experience… (10.3390/ijns6010004)	ORCID	38.60	34
13	Point-of-Care Testing for G6PD Deficiency: Opportunities for… (10.3390/ijns4040034)	ORCID	38.29	33
14	Robert Guthrie and the Trials and Tribulations of Newborn Sc… (10.3390/ijns7010005)	ORCID	37.63	31
15	Evaluation of a Two-Tier Screening Pathway for Congenital Ad… (10.3390/ijns6030063)	ORCID	37.28	30
16	Introducing and Expanding Newborn Screening in the MENA Regi… (10.3390/ijns6010012)	References	36.56	28
17	The Role of Extended CFTR Gene Sequencing in Newborn Screeni… (10.3390/ijns6010023)	ORCID	36.56	28
18	Newborn Screening for X-Linked Adrenoleukodystrophy: Review… (10.3390/ijns8020024)	ORCID	35.78	26
19	Cost and Cost-Effectiveness Assessments of Newborn Screening… (10.3390/ijns3040034)	ORCID	35.37	25
20	Newborn Screening for Mucopolysaccharidosis Type II in Illin… (10.3390/ijns6030073)	ORCID	35.37	25
21	Newborn Screening for X-Linked Adrenoleukodystrophy: The Ini… (10.3390/ijns8010006)	ORCID	35.37	25
22	A Public Dialogue to Inform the Use of Wider Genomic Testing… (10.3390/ijns8020032)	ORCID	35.37	25
23	Current State of the Art of Newborn Screening for Lysosomal… (10.3390/ijns4030024)	ORCID	34.95	24
24	Newborn Screening for Sickle Cell Disease: Indian Experience (10.3390/ijns4040031)	ORCID	34.95	24
25	Wisconsin’s Screening Algorithm for the Identification of Ne… (10.3390/ijns5030033)	ORCID	34.95	24
26	Measurement of 17-Hydroxyprogesterone by LCMSMS Improves New… (10.3390/ijns6010006)	ORCID	34.95	24
27	History of Newborn Screening for Cystic Fibrosis—The Early Y… (10.3390/ijns6010008)	ORCID	34.95	24
28	The Neonatal Screening Program in Brazil, Focus on Sickle Ce… (10.3390/ijns5010011)	ORCID	34.51	23
29	Advances in the Diagnosis and Treatment of Krabbe Disease (10.3390/ijns7030057)	ORCID	34.51	23
30	Newborn Screening for Severe Combined Immunodeficiency in Is… (10.3390/ijns3020013)	ORCID	33.06	20
31	Assessing the Performance of Dried-Blood-Spot DNA Extraction… (10.3390/ijns6020036)	ORCID	33.06	20
32	Newborn Screening for Krabbe Disease—Illinois Experience: Ro… (10.3390/ijns7020024)	ORCID	32.53	19
33	Newborn Screening for Spinal Muscular Atrophy: Variations in… (10.3390/ijns10030058)	ORCID	31.97	18
34	Early Detection and Diagnosis of Neonatal Intrahepatic Chole… (10.3390/ijns4010005)	ORCID	31.97	18
35	Newborn Screening in Japan—2021 (10.3390/ijns8010003)	ORCID	31.97	18
36	Ethical and Psychosocial Implications of Genomic Newborn Scr… (10.3390/ijns7010002)	ORCID	31.38	17
37	Follow-Up for an Abnormal Newborn Screen for Severe Combined… (10.3390/ijns6030052)	ORCID	30.10	15
38	The Changing Face of Cystic Fibrosis and Its Implications fo… (10.3390/ijns6030054)	ORCID	30.10	15
39	12th ISNS European Regional Meeting Oral and Poster Abstract… (10.3390/ijns7040071)	References ORCID	30.10	3
40	Reliability of Neonatal Screening Results (10.3390/ijns4030028)	References	29.40	14
41	Newborn Screening: Current Status in Alberta, Canada (10.3390/ijns5040037)	ORCID	29.40	14
42	Newborn Screening for CAH—Challenges and Opportunities (10.3390/ijns7010011)	ORCID	29.40	14
43	Newborn Screening for X-Linked Adrenoleukodystrophy: Past, P… (10.3390/ijns8010016)	ORCID	29.40	14
44	Mini-Review: Challenges in Newborn Screening for Urea Cycle… (10.3390/ijns1010027)	ORCID	28.65	13
45	The Impact of Seasonal Changes on Thyroxine and Thyroid-Stim… (10.3390/ijns7010008)	ORCID	28.65	13
46	Barriers to the Implementation of Newborn Pulse Oximetry Scr… (10.3390/ijns4010004)	ORCID	27.85	12
47	European Union Should Actively Stimulate and Harmonise Neona… (10.3390/ijns4040032)	ORCID	27.85	12
48	Pancreatitis-Associated Protein in Neonatal Screening for Cy… (10.3390/ijns6020028)	ORCID	27.85	12
49	Max Wilson and the Principles and Practice of Screening for… (10.3390/ijns6010015)	ORCID	26.98	11
50	The Impact of Post-Analytical Tools on New York Screening fo… (10.3390/ijns6030065)	ORCID	26.98	11